Published : 10 Jan 2022

---

Aagami’s French biotech client has further extended its contract with Aagami for a period of 6 months. This is the fourth extension and is a proven indication of client satisfaction and trust Aagami team are able to earn, nurture and maintain.

 

On 31 December 2021, Aagami brought about an exciting milestone for the client. A term sheet was signed with a Pharma company. More discussions for multiple markets are in progress.

 

 Aagami are also representing the client in Biotech Showcase 2022 (Jan10-19).